Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 169 entries
Sorted by: Best Match Show Resources per page
Long-term Multi-product Facial Regimen in Subjects with Moderate-to-severe Photodamage and Hyperpigmentation.

The Journal of clinical and aesthetic dermatology

Herndon JH, Makino ET, Jiang LI, Stephens TJ, Mehta RC.
PMID: 26345199
J Clin Aesthet Dermatol. 2015 Aug;8(8):16-21.

BACKGROUND: Photoaged skin is primarily a result of chronic sun exposure. Irregular pigmentation and wrinkling are common clinical manifestations. Monotherapy with retinoids, growth factors, and skin lighteners have proven beneficial. However, long-term treatment with a multi-product facial regimen has...

Cite
Herndon JH, Makino ET, Jiang LI, et al. Long-term Multi-product Facial Regimen in Subjects with Moderate-to-severe Photodamage and Hyperpigmentation. J Clin Aesthet Dermatol. 2015;8(8):16-21
Herndon, J. H., Makino, E. T., Jiang, L. I., Stephens, T. J., & Mehta, R. C. (2015). Long-term Multi-product Facial Regimen in Subjects with Moderate-to-severe Photodamage and Hyperpigmentation. The Journal of clinical and aesthetic dermatology, 8(8), 16-21.
Herndon, James H, et al. "Long-term Multi-product Facial Regimen in Subjects with Moderate-to-severe Photodamage and Hyperpigmentation." The Journal of clinical and aesthetic dermatology vol. 8,8 (2015): 16-21.
Herndon JH, Makino ET, Jiang LI, Stephens TJ, Mehta RC. Long-term Multi-product Facial Regimen in Subjects with Moderate-to-severe Photodamage and Hyperpigmentation. J Clin Aesthet Dermatol. 2015 Aug;8(8):16-21. PMID: 26345199; PMCID: PMC4557846.
Copy Download .nbib Format: NLM
Facial primer provides immediate and long-term improvements in mild-to-moderate facial hyperpigmentation and fine lines associated with photoaging.

Clinical, cosmetic and investigational dermatology

Roberts WE, Jiang LI, Herndon JH.
PMID: 26366102
Clin Cosmet Investig Dermatol. 2015 Sep 02;8:471-7. doi: 10.2147/CCID.S88443. eCollection 2015.

BACKGROUND: Photoaged skin results from various environmental factors, most importantly chronic sun exposure. Dyschromia and fine lines/wrinkles are common clinical manifestations of photodamaged skin.PURPOSE: This single-center clinical trial was conducted to assess the efficacy and tolerability of a new...

Cite
Roberts WE, Jiang LI, Herndon JH. Facial primer provides immediate and long-term improvements in mild-to-moderate facial hyperpigmentation and fine lines associated with photoaging. Clin Cosmet Investig Dermatol. 2015;8:471-7doi: 10.2147/CCID.S88443.
Roberts, W. E., Jiang, L. I., & Herndon, J. H. (2015). Facial primer provides immediate and long-term improvements in mild-to-moderate facial hyperpigmentation and fine lines associated with photoaging. Clinical, cosmetic and investigational dermatology, 8471-7. https://doi.org/10.2147/CCID.S88443
Roberts, Wendy E, et al. "Facial primer provides immediate and long-term improvements in mild-to-moderate facial hyperpigmentation and fine lines associated with photoaging." Clinical, cosmetic and investigational dermatology vol. 8 (2015): 471-7. doi: https://doi.org/10.2147/CCID.S88443
Roberts WE, Jiang LI, Herndon JH. Facial primer provides immediate and long-term improvements in mild-to-moderate facial hyperpigmentation and fine lines associated with photoaging. Clin Cosmet Investig Dermatol. 2015 Sep 02;8:471-7. doi: 10.2147/CCID.S88443. eCollection 2015. PMID: 26366102; PMCID: PMC4562739.
Copy Download .nbib Format: NLM
Effects of the nephrilin peptide on post-burn glycemic control, renal function, fat and lean body mass, and wound healing.

International journal of burns and trauma

Mascarenhas DD, Ayadi AE, Wetzel M, Prasai A, Mifflin R, Jay J, Herndon DN, Finnerty CC.
PMID: 28078180
Int J Burns Trauma. 2016 Nov 30;6(3):44-50. eCollection 2016.

The mechanisms underlying the effects of severe burn trauma are not well understood. We previously demonstrated the ability of nephrilin peptide (an iron-binding peptide believed to enter cells through iron-uptake pathways) to suppress aspects of the neuroinflammatory response in...

Cite
Mascarenhas DD, Ayadi AE, Wetzel M, et al. Effects of the nephrilin peptide on post-burn glycemic control, renal function, fat and lean body mass, and wound healing. Int J Burns Trauma. 2016;6(3):44-50
Mascarenhas, D. D., Ayadi, A. E., Wetzel, M., Prasai, A., Mifflin, R., Jay, J., Herndon, D. N., & Finnerty, C. C. (2016). Effects of the nephrilin peptide on post-burn glycemic control, renal function, fat and lean body mass, and wound healing. International journal of burns and trauma, 6(3), 44-50.
Mascarenhas, Desmond D, et al. "Effects of the nephrilin peptide on post-burn glycemic control, renal function, fat and lean body mass, and wound healing." International journal of burns and trauma vol. 6,3 (2016): 44-50.
Mascarenhas DD, Ayadi AE, Wetzel M, Prasai A, Mifflin R, Jay J, Herndon DN, Finnerty CC. Effects of the nephrilin peptide on post-burn glycemic control, renal function, fat and lean body mass, and wound healing. Int J Burns Trauma. 2016 Nov 30;6(3):44-50. eCollection 2016. PMID: 28078180; PMCID: PMC5218868.
Copy Download .nbib Format: NLM
Differences in the Association between Depression and Opioid Misuse in Chronic Low Back Pain versus Chronic Pain at Other Locations.

Healthcare (Basel, Switzerland)

Jaiswal A, Scherrer JF, Salas J, van den Berk-Clark C, Fernando S, Herndon CM.
PMID: 27417622
Healthcare (Basel). 2016 Jun 16;4(2). doi: 10.3390/healthcare4020034.

Patients with chronic pain and depression are more likely to develop opioid abuse compared to patients without depression. It is not known if this association differs by pain location. We compared the strength of association between depression and opioid...

Cite
Jaiswal A, Scherrer JF, Salas J, et al. Differences in the Association between Depression and Opioid Misuse in Chronic Low Back Pain versus Chronic Pain at Other Locations. Healthcare (Basel). 2016;4(2)doi: 10.3390/healthcare4020034.
Jaiswal, A., Scherrer, J. F., Salas, J., van den Berk-Clark, C., Fernando, S., & Herndon, C. M. (2016). Differences in the Association between Depression and Opioid Misuse in Chronic Low Back Pain versus Chronic Pain at Other Locations. Healthcare (Basel, Switzerland), 4(2), . https://doi.org/10.3390/healthcare4020034
Jaiswal, Arpana, et al. "Differences in the Association between Depression and Opioid Misuse in Chronic Low Back Pain versus Chronic Pain at Other Locations." Healthcare (Basel, Switzerland) vol. 4,2 (2016). doi: https://doi.org/10.3390/healthcare4020034
Jaiswal A, Scherrer JF, Salas J, van den Berk-Clark C, Fernando S, Herndon CM. Differences in the Association between Depression and Opioid Misuse in Chronic Low Back Pain versus Chronic Pain at Other Locations. Healthcare (Basel). 2016 Jun 16;4(2). doi: 10.3390/healthcare4020034. PMID: 27417622; PMCID: PMC4934587.
Copy Download .nbib Format: NLM
History of metabolic treatments in burn care.

Wounds : a compendium of clinical research and practice

Al-Mousawi AM, Jeschke MG, Herndon DN.
PMID: 25942607
Wounds. 2008 Jul;20(7):185-91.

This article discusses the recent history of advances in burn care and increased understanding that have led to achievements in modulating the metabolic response following burn injury and significant improvements in patient outcomes. The authors describe the development of...

Cite
Al-Mousawi AM, Jeschke MG, Herndon DN. History of metabolic treatments in burn care. Wounds. 2008;20(7):185-91
Al-Mousawi, A. M., Jeschke, M. G., & Herndon, D. N. (2008). History of metabolic treatments in burn care. Wounds : a compendium of clinical research and practice, 20(7), 185-91.
Al-Mousawi, Ahmed M, et al. "History of metabolic treatments in burn care." Wounds : a compendium of clinical research and practice vol. 20,7 (2008): 185-91.
Al-Mousawi AM, Jeschke MG, Herndon DN. History of metabolic treatments in burn care. Wounds. 2008 Jul;20(7):185-91. PMID: 25942607.
Copy Download .nbib Format: NLM
A Marine Protein-based Dietary Supplement for Subclinical Hair Thinning/Loss: Results of a Multisite, Double-blind, Placebo-controlled Clinical Trial.

International journal of trichology

Rizer RL, Stephens TJ, Herndon JH, Sperber BR, Murphy J, Ablon GR.
PMID: 26903744
Int J Trichology. 2015 Oct-Dec;7(4):156-66. doi: 10.4103/0974-7753.171573.

INTRODUCTION: Since skin and hair quality are potent vitality signals, and hair growth deficiency can cause significant psychological morbidity. In addition to clearly-defined hair loss disorders, milder forms of hair thinning or hair loss appear to be increasingly common,...

Cite
Rizer RL, Stephens TJ, Herndon JH, et al. A Marine Protein-based Dietary Supplement for Subclinical Hair Thinning/Loss: Results of a Multisite, Double-blind, Placebo-controlled Clinical Trial. Int J Trichology. 2015;7(4):156-66doi: 10.4103/0974-7753.171573.
Rizer, R. L., Stephens, T. J., Herndon, J. H., Sperber, B. R., Murphy, J., & Ablon, G. R. (2015). A Marine Protein-based Dietary Supplement for Subclinical Hair Thinning/Loss: Results of a Multisite, Double-blind, Placebo-controlled Clinical Trial. International journal of trichology, 7(4), 156-66. https://doi.org/10.4103/0974-7753.171573
Rizer, Ronald L, et al. "A Marine Protein-based Dietary Supplement for Subclinical Hair Thinning/Loss: Results of a Multisite, Double-blind, Placebo-controlled Clinical Trial." International journal of trichology vol. 7,4 (2015): 156-66. doi: https://doi.org/10.4103/0974-7753.171573
Rizer RL, Stephens TJ, Herndon JH, Sperber BR, Murphy J, Ablon GR. A Marine Protein-based Dietary Supplement for Subclinical Hair Thinning/Loss: Results of a Multisite, Double-blind, Placebo-controlled Clinical Trial. Int J Trichology. 2015 Oct-Dec;7(4):156-66. doi: 10.4103/0974-7753.171573. PMID: 26903744; PMCID: PMC4738482.
Copy Download .nbib Format: NLM
Physiologic and molecular changes in the tracheal epithelium of rats following burn injury.

International journal of burns and trauma

Jacob S, Zhu Y, Kraft R, Cotto C, Carmical JR, Wood TG, Enkhbaatar P, Herndon DN, Hawkins HK, Cox RA.
PMID: 26064800
Int J Burns Trauma. 2015 Mar 20;5(1):36-45. eCollection 2015.

Pneumonia is the leading complication in the critical care of burn victims. Airway epithelial dysfunction compromises host defense against pneumonia. The aim of this study is to test the hypothesis that burn injury alters the physiology of the airway...

Cite
Jacob S, Zhu Y, Kraft R, et al. Physiologic and molecular changes in the tracheal epithelium of rats following burn injury. Int J Burns Trauma. 2015;5(1):36-45
Jacob, S., Zhu, Y., Kraft, R., Cotto, C., Carmical, J. R., Wood, T. G., Enkhbaatar, P., Herndon, D. N., Hawkins, H. K., & Cox, R. A. (2015). Physiologic and molecular changes in the tracheal epithelium of rats following burn injury. International journal of burns and trauma, 5(1), 36-45.
Jacob, Sam, et al. "Physiologic and molecular changes in the tracheal epithelium of rats following burn injury." International journal of burns and trauma vol. 5,1 (2015): 36-45.
Jacob S, Zhu Y, Kraft R, Cotto C, Carmical JR, Wood TG, Enkhbaatar P, Herndon DN, Hawkins HK, Cox RA. Physiologic and molecular changes in the tracheal epithelium of rats following burn injury. Int J Burns Trauma. 2015 Mar 20;5(1):36-45. eCollection 2015. PMID: 26064800; PMCID: PMC4448086.
Copy Download .nbib Format: NLM
Nuclear georeactor origin of oceanic basalt 3He/4He, evidence, and implications.

Proceedings of the National Academy of Sciences of the United States of America

Herndon JM.
PMID: 12615991
Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3047-50. doi: 10.1073/pnas.0437778100. Epub 2003 Mar 03.

Nuclear georeactor numerical simulation results yield substantial (3)He and (4)He production and (3)He(4)He ratios relative to air (R(A)) that encompass the entire 2-SD (2sigma) confidence level range of tabulated measured (3)He(4)He ratios of basalts from along the global spreading...

Cite
Herndon JM. Nuclear georeactor origin of oceanic basalt 3He/4He, evidence, and implications. Proc Natl Acad Sci U S A. 2003;100(6):3047-50doi: 10.1073/pnas.0437778100.
Herndon, J. M. (2003). Nuclear georeactor origin of oceanic basalt 3He/4He, evidence, and implications. Proceedings of the National Academy of Sciences of the United States of America, 100(6), 3047-50. https://doi.org/10.1073/pnas.0437778100
Herndon, J Marvin. "Nuclear georeactor origin of oceanic basalt 3He/4He, evidence, and implications." Proceedings of the National Academy of Sciences of the United States of America vol. 100,6 (2003): 3047-50. doi: https://doi.org/10.1073/pnas.0437778100
Herndon JM. Nuclear georeactor origin of oceanic basalt 3He/4He, evidence, and implications. Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3047-50. doi: 10.1073/pnas.0437778100. Epub 2003 Mar 03. PMID: 12615991; PMCID: PMC152243.
Copy Download .nbib Format: NLM
Genetic factors in the etiology of mental retardation.

International record of medicine and general practice clinics

GOODMAN HO, HERNDON CN.
PMID: 13620361
Int Rec Med Gen Pract Clin. 1959 Feb;172(2):61-74.

No abstract available.

Cite
GOODMAN HO, HERNDON CN. Genetic factors in the etiology of mental retardation. Int Rec Med Gen Pract Clin. 1959;172(2):61-74
GOODMAN, H. O., & HERNDON, C. N. (1959). Genetic factors in the etiology of mental retardation. International record of medicine and general practice clinics, 172(2), 61-74.
GOODMAN, H O, and HERNDON, C N. "Genetic factors in the etiology of mental retardation." International record of medicine and general practice clinics vol. 172,2 (1959): 61-74.
GOODMAN HO, HERNDON CN. Genetic factors in the etiology of mental retardation. Int Rec Med Gen Pract Clin. 1959 Feb;172(2):61-74. PMID: 13620361.
Copy Download .nbib Format: NLM
Genetics in medical education.

Journal of medical education

HERNDON CN.
PMID: 14392442
J Med Educ. 1955 Jul;30(7):407-10.

No abstract available.

Cite
HERNDON CN. Genetics in medical education. J Med Educ. 1955;30(7):407-10
HERNDON, C. N. (1955). Genetics in medical education. Journal of medical education, 30(7), 407-10.
HERNDON, C N. "Genetics in medical education." Journal of medical education vol. 30,7 (1955): 407-10.
HERNDON CN. Genetics in medical education. J Med Educ. 1955 Jul;30(7):407-10. PMID: 14392442.
Copy Download .nbib Format: NLM
Ureteroscopy in children: is there a need for ureteral dilation and postoperative stenting?.

Journal of pediatric urology

Herndon CD, Viamonte L, Joseph DB.
PMID: 18947623
J Pediatr Urol. 2006 Aug;2(4):290-3. doi: 10.1016/j.jpurol.2005.10.011. Epub 2006 Mar 20.

INTRODUCTION: Ureteroscopic stone manipulation and extraction is the standard of care for distal stone disease in the adult population. Recently, with refinements in instrumentation, these standards have been applied in pediatrics. Here, we investigate the role of ureteral dilation...

Cite
Herndon CD, Viamonte L, Joseph DB. Ureteroscopy in children: is there a need for ureteral dilation and postoperative stenting?. J Pediatr Urol. 2006;2(4):290-3doi: 10.1016/j.jpurol.2005.10.011.
Herndon, C. D., Viamonte, L., & Joseph, D. B. (2006). Ureteroscopy in children: is there a need for ureteral dilation and postoperative stenting?. Journal of pediatric urology, 2(4), 290-3. https://doi.org/10.1016/j.jpurol.2005.10.011
Herndon, C D Anthony, et al. "Ureteroscopy in children: is there a need for ureteral dilation and postoperative stenting?." Journal of pediatric urology vol. 2,4 (2006): 290-3. doi: https://doi.org/10.1016/j.jpurol.2005.10.011
Herndon CD, Viamonte L, Joseph DB. Ureteroscopy in children: is there a need for ureteral dilation and postoperative stenting?. J Pediatr Urol. 2006 Aug;2(4):290-3. doi: 10.1016/j.jpurol.2005.10.011. Epub 2006 Mar 20. PMID: 18947623.
Copy Download .nbib Format: NLM
Treatment of multiple sclerosis with the interferon-betas: comparative risks and benefits.

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Herndon RM.
PMID: 18020615
BioDrugs. 1998 Dec;10(6):463-70. doi: 10.2165/00063030-199810060-00004.

Several inteferons (IFNs) have recently been introduced for the treatment of multiple sclerosis (MS). These are IFNbeta-1b (Betaseron) and 2 IFNbeta-1a preparations (Avonex and Rebif). All 3 drugs reduce the number of acute exacerbations in relapsing remitting MS by...

Cite
Herndon RM. Treatment of multiple sclerosis with the interferon-betas: comparative risks and benefits. BioDrugs. 1998;10(6):463-70doi: 10.2165/00063030-199810060-00004.
Herndon, R. M. (1998). Treatment of multiple sclerosis with the interferon-betas: comparative risks and benefits. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 10(6), 463-70. https://doi.org/10.2165/00063030-199810060-00004
Herndon, R M. "Treatment of multiple sclerosis with the interferon-betas: comparative risks and benefits." BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy vol. 10,6 (1998): 463-70. doi: https://doi.org/10.2165/00063030-199810060-00004
Herndon RM. Treatment of multiple sclerosis with the interferon-betas: comparative risks and benefits. BioDrugs. 1998 Dec;10(6):463-70. doi: 10.2165/00063030-199810060-00004. PMID: 18020615.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 169 entries